TRANSPLANT PRACTICES WITH EXPERT’S OPINION & DISCUSSION ON RISK STRATIFICATION AND CHOICE OF INDUCTION AGENT IN KIDNEY TRANSPLANT

Our Faculty

Dr Nassim Kamar

• Dr Nassim Kamar (MD, PhD) is a Professor of Nephrology.
• He is in charge of the organ Transplant Unit at the Department of Nephrology and Organ Transplantation, Toulouse University Hospital, France.
• He is a Member of the Council of the International Transplant Infectious Disease Society.
• His particular interests are viral infection, particularly hepatitis E virus, hepatitis C virus, and cytomegalovirus infections that develop after solid organ transplantation, as well as immunosuppressive therapy in heart, liver, kidney, and kidney-pancreas transplant patients.

Dr Abi Abraham

MBBS, MD, DM, DNB

• Dr. Abi Abraham M has over 27 years of clinical and academic experience (after DM).
• He specialises in kidney transplantation, critical care nephrology, vasculitis, lupus, and electrolyte problems.
• He has received three prestigious scholarships, has extensively recognised papers in peer-reviewed journals, is a member of numerous renal societies, and has held managerial roles in organisations.
• He was a Nephrology Associate Professor at Christian Medical College in Vellore. In the previous 16 years, Lakeshore Hospital has performed over 1600 renal transplants.

Dr Urmila Anandh

MBBS, MD, DM, DNB

• With an illustrious career of over 25 years, Dr.Urmila Anandh is a revered nephrologist.
• She is an award-winning medical professional and has performed several kidney transplantations successfully.
• In addition to her admirable skills, she is recognized for providing safe and effective treatments to kidney patients of all age groups.
• Dr. Urmila Anandh has worked at reputed institutions in the past. At present, she heads the Department of Nephrology at Amrita Hospital in Faridabad, Haryana, India.

Learning Objectives

• Importance of risk stratification and role of induction therapy in kidney transplants with a focus on special patient population:
  • Reduce the risk of CMV and BKV infections
  • ABOi transplant
  • Malignancy
  • lymphopenia (focus more on infection)
• Algorithm to guide choice of Induction Agent.
• IL2i as an induction agent to reduce the risk of infection in kidney transplant.
• IL2i in a case of infection (D+ R+) (D+R-)

Agenda

Copyright: All rights reserved. No part of this website content may be reproduced, stored in retrieval system, tapes, discs, microfilms etc., or transmitted in any form or by any means electronic, mechanical,
photocopies, recording or otherwise, without the written permission of Insignia Learning Pvt. Ltd., Mumbai.